Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management?

Arushi Jain, Director, Akums Drugs & Pharmaceuticals Limited

In an interaction with India Pharma Outlook, Arushi Jain, Director at Akums Drugs & Pharmaceuticals Limited, discussed India’s growing nutraceutical sector, driven by rising health awareness and chronic diseases. She highlighted its integration with

Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care

Vineet Dwivedi, Global Head, Alcon Global Services

In an interaction with India Pharma Outlook, Vineet Dwivedi, Global Head, Alcon Global Services, discusses how employee engagement in the pharmaceutical industry has evolved to focus on well-being, flexibility, diversity, and career growth.

Strategic finance for pharmaceutical innovation and stability

Melagiri Sridhar, Chief Financial Officer, Bafna Pharmaceuticals

Melagiri Sridhar, Chief Financial Officer, Bafna Pharmaceuticals in a recent interaction with India Pharma Outlook, shared his views on how CFOs in the pharmaceutical industry should balance investments in advanced stability-enhancing technologies...

How Organic Synthesis is Accelerating Drug Discovery in Pharma

Ajay Bhardwaj, CEO, Anthem Biosciences Private Limited

In an interaction with India Pharma Outlook, Ajay Bhardwaj, CEO, Anthem Biosciences Private Limited discusses about the role of organic synthesis in accelerating drug discovery, highlighted the significance of diligence at an early stage, AI-driven..

Gender Gap in Healthcare: Why Women's Health Needs More Research

Vivek Soares, Country Lead, India and South Asia, Organon

In an interaction with India Pharma Outlook, Vivek Soares, Country Lead, India and South Asia, Organon, discusses the progress and gaps in women’s healthcare, emphasizing the need for gender-specific research, improved access, policy reforms...

Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India

Sanjay Vyas, President, Global Head Safety Services and Clinical Logistics and Managing Director...

In an interaction with India Pharma Outlook, Sanjay Vyas, President, Global Head of Safety Services &Clinical Logistics, and Managing Director, India at Parexel, discusses ways in which Indian pharma firmsstrengthen clinical trial supply chains

© 2025 India Pharma Outlook. All Rights Reserved.